Shuchi Nahar's Weekend Blog!

CAPEX Acceleration in Indian Chemical Companies -  USD 300 bn  domestic market by 2025 Twitter Handle: @shuchi_nahar India’s chemical industry was estimated to be worth USD 178 billion in FY 2019-20 and has a significant potential to reach USD 300 billion by FY 2024-25. In terms of demand, the industry has grown at approximately 1.3 times the country’s average GDP growth in the last five years and shows a strong linkage with its GDP. Indian specialty chemical sector has grown at 12%+ in the last five years and is well poised to expand its global market share to 7-8% from 4% in the coming years. The structural drivers are in place like global best practice manufacturing standard and R&D capability along with government impetus of make in India policy with pro-growth policies will act as a further catalyst for growth. Further, a global MNC looking at China Plus one strategy will help Indian incumbents to gain market share. In the short to medium term, supply disruptions emerging

Recent disruption in China - Impact on Indian Chemical Companies Twitter Handle: @shuchi_nahar Specialty Chemical Article: https://myweekendspot.blogspot.com/2021/07/speciality-chemicals-market-size-demand.html Government scheme to boost: https://myweekendspot.blogspot.com/2021/07/government-initiatives-to-boost-growth.html Indian specialty chemicals companies are poised to ride tailwinds from macro drivers including ‘China+1’, import-substitution, growing costs within China (capital, operational, compliances), and currency benefits.  Recent disruptions in China will cause medium-term challenges for downstream producers while benefiting base chemical suppliers. More importantly, these frequent supply disruptions in China further strengthen the case for quality Indian players in the chemical domain. Growing import substitution by local industry makes a case for strengthening volume growth for base chemical/intermediate suppliers.  Recent disruptions in China (electricity shortages,

Syngene International Ltd. FY2020-21 Annual Report Key Takeaways  In continuation of my previous blog here is the updated version l ink to Initial Blog -  https://myweekendspot.blogspot.com/2020/10/syngene-next-giant-player-for-cdmo.html Company Overview Incorporated in 1994 as a subsidiary of Biocon, Syngene International (SIL) is a leading contract research organization (CRO), which supports R&D programs of global innovative companies.   SIL offers outsourced services to support discovery and development for organizations across industrial sectors like pharmaceuticals, biopharmaceuticals, nutraceuticals, animal health, agrochemicals, etc. It currently caters to 400+ global players including Bristol-Myers Squibb (BMS), Abbott, Baxter, and Amgen, among others. SIL derives 95% of its revenues from exports.   Syngene continued to build on its integrated drug discovery and development portfolio during the year, including a five-year collaboration with 3DC, the drug discovery

Ethanol - Global Production, Capacity, Impact, and Ethanol Blending Trend Twitter Handle: @shuchi_nahar In continuation with the previous Ethanol blog here is an extended version with more new Insights! With a view to give a boost to the agriculture sector and to reduce environmental pollution, the government of India had launched pilot projects in 2001 wherein, 5% ethanol blended petrol was supplied to retail outlets. Apart from field trials, R&D studies were also simultaneously conducted. The success of these field trials and studies paved the way for EBP in India. The Government of India vide its Resolution dated 3rd September 2002 decided to launch Ethanol Blended Petrol (EBP) Program in January 2003 for sale of 5% ethanol blended petrol in nine States and four UTs.   The global production of fuel ethanol touched 110 billion liters in 2019 showing an average growth of 4% a year per year during the last decade. The United States of America (USA) and Brazil contribute for 92

Teleconsultation - The  game-changer for the Animal Healthcare Industry Twitter Handle: @shuchi_nahar Telemedicine, telehealth and teleconsulting are currently top of mind to the animal health and pet owners alike, however, leading veterinarians in the industry elaborated that this digital offering of veterinary services has been on the rise for the past five years and has only been accelerated with the Coronavirus pandemic. The global veterinary telehealth market size was valued at USD 92.0 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 19.5% from 2021 to 2028. The growing adoption of these management systems can be attributed to the steady growth in the focus on veterinary telehealth along with disease detection. Furthermore, there is high demand and an increasing rate of consumption for animal-derived products is anticipated to drive the market. This growing demand is eventually increasing the need to protect animals from diseases. Telehealth

Biotechnology the Natural Beauty Booster - Good for Health and Earth! Twitter Handle: @shuchi_nahar The applications of biotechnology are so extensive that, currently, almost all industries can use this technology. This means that these industries can produce new or better products faster and more efficiently. Biotech beauty technically refers to ingredients that are generated with DNA editing and the help of organisms like algae, yeast, or bacteria. Biosynthesis is a multi-step, enzyme-catalyzed process where substrates are converted into more complex products in living organisms. In the biosynthesis stage, simple compounds are modified, converted, or joined together to form macromolecules. Compounds like hyaluronic acid, squalane, and even collagen can be produced at high levels and in a completely pure and environmentally responsible way. In many ways, biotech can improve on what Mother Nature has provided through evolution. Then the building blocks of organic compounds are isola